Drug Database
Back to search

Netherlands· NL-e468b695b136

Ecalta 100 mg, poeder voor concentraat voor oplossing voor intraveneuze infusie

A anidulafungin product containing anidulafungine, fructose mengsel, registered in Netherlands by Pfizer Europe MA EEIG. The same ATC class is registered in 16 of our 19 countries.

ATC J02AX06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEcalta 100 mg, poeder voor concentraa…ATCJ02AX06REGISTER NO.NL-e468b695b136PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about anidulafungine, fructose mengselAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Anidulafungin is registered in 16 of 19 countries.

Countries holding a registration under ATC J02AX06 (anidulafungin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search anidulafungin products by name

Anidulafungin · ATC J02AX06

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of anidulafungin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Anidulafungin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$460.55
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ANIDULAFUNGINE, FRUCTOSE MENGSEL
Manufacturer
Pfizer Europe MA EEIG
Country
Netherlands (NL)
ATC code
J02AX06
ATC class
Anidulafungin
Defined daily dose
0.1 g, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/07/416

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for anidulafungin.

Graded by severity as the source publishes them — 1 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check anidulafungin against other medicinesHow interaction checks work

Anidulafungin · interactions on record

1 record

  • 1 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same class

    Other records under J02AX06

    Anidulafungin, as other registers publish it.

    All anidulafungin products

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/353415e7-8a1e-49e0-8a3e-4ea3cdcf46ab
GET /v1/drugs/353415e7-8a1e-49e0-8a3e-4ea3cdcf46ab?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Poeder voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ecalta-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Anidulafungin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp103455",
  "excipients": [
    "FRUCTOSE",
    "MANNITOL (D-) (E 421)",
    "NATRIUMHYDROXIDE (E 524)",
    "POLYSORBAAT 80 (E 433)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WIJNSTEENZUUR, (L (+) Vorm) (E 334)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "ANIDULAFUNGINE, FRUCTOSE MENGSEL"
  ],
  "leaflet_url": null,
  "authorised_at": "2009/07/27",
  "procedure_number": "EMEA/H/C/000788",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/07/416",
  "additional_monitoring": "N"
}
    API referenceMCP serverPlans

    See everything about anidulafungin.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console